308 related articles for article (PubMed ID: 21426372)
1. SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.
Lazaar AL; Sweeney LE; MacDonald AJ; Alexis NE; Chen C; Tal-Singer R
Br J Clin Pharmacol; 2011 Aug; 72(2):282-93. PubMed ID: 21426372
[TBL] [Abstract][Full Text] [Related]
2. SCH527123, a novel CXCR2 antagonist, inhibits ozone-induced neutrophilia in healthy subjects.
Holz O; Khalilieh S; Ludwig-Sengpiel A; Watz H; Stryszak P; Soni P; Tsai M; Sadeh J; Magnussen H
Eur Respir J; 2010 Mar; 35(3):564-70. PubMed ID: 19643947
[TBL] [Abstract][Full Text] [Related]
3. A novel flow cytometric assay of human whole blood neutrophil and monocyte CD11b levels: upregulation by chemokines is related to receptor expression, comparison with neutrophil shape change, and effects of a chemokine receptor (CXCR2) antagonist.
Nicholson GC; Tennant RC; Carpenter DC; Sarau HM; Kon OM; Barnes PJ; Salmon M; Vessey RS; Tal-Singer R; Hansel TT
Pulm Pharmacol Ther; 2007; 20(1):52-9. PubMed ID: 16406722
[TBL] [Abstract][Full Text] [Related]
4. The pharmacokinetics and pharmacodynamics of danirixin (GSK1325756)--a selective CXCR2 antagonist --in healthy adult subjects.
Miller BE; Mistry S; Smart K; Connolly P; Carpenter DC; Cooray H; Bloomer JC; Tal-Singer R; Lazaar AL
BMC Pharmacol Toxicol; 2015 Jun; 16():18. PubMed ID: 26092545
[TBL] [Abstract][Full Text] [Related]
5. Safety and early treatment effects of the CXCR2 antagonist SB-656933 in patients with cystic fibrosis.
Moss RB; Mistry SJ; Konstan MW; Pilewski JM; Kerem E; Tal-Singer R; Lazaar AL;
J Cyst Fibros; 2013 May; 12(3):241-8. PubMed ID: 22995323
[TBL] [Abstract][Full Text] [Related]
6. LPS challenge in healthy subjects: an investigation of neutrophil chemotaxis mechanisms involving CXCR1 and CXCR2.
Aul R; Patel S; Summerhill S; Kilty I; Plumb J; Singh D
Int Immunopharmacol; 2012 Jul; 13(3):225-31. PubMed ID: 22561413
[TBL] [Abstract][Full Text] [Related]
7. Downmodulation of CXCL8/IL-8 receptors on neutrophils after recruitment in the airways.
Pignatti P; Moscato G; Casarini S; Delmastro M; Poppa M; Brunetti G; Pisati P; Balbi B
J Allergy Clin Immunol; 2005 Jan; 115(1):88-94. PubMed ID: 15637552
[TBL] [Abstract][Full Text] [Related]
8. Combined anti CXC receptors 1 and 2 therapy is a promising anti-inflammatory treatment for respiratory diseases by reducing neutrophil migration and activation.
Planagumà A; Domènech T; Pont M; Calama E; García-González V; López R; Aulí M; López M; Fonquerna S; Ramos I; de Alba J; Nueda A; Prats N; Segarra V; Miralpeix M; Lehner MD
Pulm Pharmacol Ther; 2015 Oct; 34():37-45. PubMed ID: 26271598
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of LPS-induced airway neutrophilic inflammation in healthy volunteers with an oral CXCR2 antagonist.
Leaker BR; Barnes PJ; O'Connor B
Respir Res; 2013 Dec; 14(1):137. PubMed ID: 24341382
[TBL] [Abstract][Full Text] [Related]
10. The effect of a selective CXCR2 antagonist (AZD5069) on human blood neutrophil count and innate immune functions.
Jurcevic S; Humfrey C; Uddin M; Warrington S; Larsson B; Keen C
Br J Clin Pharmacol; 2015 Dec; 80(6):1324-36. PubMed ID: 26182832
[TBL] [Abstract][Full Text] [Related]
11. The effects of a CXCR1/CXCR2 antagonist on neutrophil migration in mild atopic asthmatic subjects.
Todd CM; Salter BM; Murphy DM; Watson RM; Howie KJ; Milot J; Sadeh J; Boulet LP; O'Byrne PM; Gauvreau GM
Pulm Pharmacol Ther; 2016 Dec; 41():34-39. PubMed ID: 27640067
[TBL] [Abstract][Full Text] [Related]
12. CXCR2 antagonists block the N-Ac-PGP-induced neutrophil influx in the airways of mice, but not the production of the chemokine CXCL1.
Braber S; Overbeek SA; Koelink PJ; Henricks PA; Zaman GJ; Garssen J; Kraneveld AD; Folkerts G
Eur J Pharmacol; 2011 Oct; 668(3):443-9. PubMed ID: 21458445
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil chemotaxis caused by chronic obstructive pulmonary disease alveolar macrophages: the role of CXCL8 and the receptors CXCR1/CXCR2.
Kaur M; Singh D
J Pharmacol Exp Ther; 2013 Oct; 347(1):173-80. PubMed ID: 23912333
[TBL] [Abstract][Full Text] [Related]
14. The chemokine receptors CXCR1/CXCR2 modulate antigen-induced arthritis by regulating adhesion of neutrophils to the synovial microvasculature.
Coelho FM; Pinho V; Amaral FA; Sachs D; Costa VV; Rodrigues DH; Vieira AT; Silva TA; Souza DG; Bertini R; Teixeira AL; Teixeira MM
Arthritis Rheum; 2008 Aug; 58(8):2329-37. PubMed ID: 18668539
[TBL] [Abstract][Full Text] [Related]
15. A synthetic, non-peptide CXCR2 antagonist blocks MIP-2-induced neutrophil migration in mice.
Matzer SP; Zombou J; Sarau HM; Röllinghoff M; Beuscher HU
Immunobiology; 2004; 209(3):225-33. PubMed ID: 15518334
[TBL] [Abstract][Full Text] [Related]
16. The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD.
Kirsten AM; Förster K; Radeczky E; Linnhoff A; Balint B; Watz H; Wray H; Salkeld L; Cullberg M; Larsson B
Pulm Pharmacol Ther; 2015 Apr; 31():36-41. PubMed ID: 25681277
[TBL] [Abstract][Full Text] [Related]
17. Endothelin-1 induces neutrophil recruitment in adaptive inflammation via TNFα and CXCL1/CXCR2 in mice.
Zarpelon AC; Pinto LG; Cunha TM; Vieira SM; Carregaro V; Souza GR; Silva JS; Ferreira SH; Cunha FQ; Verri WA
Can J Physiol Pharmacol; 2012 Feb; 90(2):187-99. PubMed ID: 22320712
[TBL] [Abstract][Full Text] [Related]
18. CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease.
Rennard SI; Dale DC; Donohue JF; Kanniess F; Magnussen H; Sutherland ER; Watz H; Lu S; Stryszak P; Rosenberg E; Staudinger H
Am J Respir Crit Care Med; 2015 May; 191(9):1001-11. PubMed ID: 25695403
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial.
Nair P; Gaga M; Zervas E; Alagha K; Hargreave FE; O'Byrne PM; Stryszak P; Gann L; Sadeh J; Chanez P;
Clin Exp Allergy; 2012 Jul; 42(7):1097-103. PubMed ID: 22702508
[TBL] [Abstract][Full Text] [Related]
20. Fluticasone propionate protects against ozone-induced airway inflammation and modified immune cell activation markers in healthy volunteers.
Alexis NE; Lay JC; Haczku A; Gong H; Linn W; Hazucha MJ; Harris B; Tal-Singer R; Peden DB
Environ Health Perspect; 2008 Jun; 116(6):799-805. PubMed ID: 18560537
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
